Last reviewed · How we verify

NCT05091645: Gr-GFI

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture

Status unknown Last updated 28 November 2023
What this trial tests

trial testing GFI in Frailty Syndrome in 89 participants. Status unknown.

Timeline
25 February 2022
Primary endpoint
30 June 2024
30 July 2024

Quick facts

Lead sponsorUniversity of Thessaly
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment89
Start date25 February 2022
Primary completion30 June 2024
Estimated completion30 July 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University of Thessaly

Who can join

65 and older, any sex, with Frailty Syndrome or Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study attempts to the translation and the cultural adaptation of the Groningen Frailty Indicator (GFI) questionnaire in the Greek population in patients suffering from hip fracture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frailty Syndrome

Currently open trials in the same condition.

Other University of Thessaly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05091645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing